GHIT Fund Global Health Innovative Technology Fund

Investment

Details

Screening project between Daiichi Sankyo RD Novare and TB Alliance
Project Completed
 
  • RFP Year
    2022
  • Awarded Amount
    $152,970
  • Disease
    Tuberculosis
  • Intervention
    Drug
  • Development Stage
    Hit Identification
  • Collaboration Partners
    Daiichi Sankyo RD Novare Co., Ltd. ,  The Global Alliance for TB Drug Development